Sorry, you need to enable JavaScript to visit this website.

Open-Label Extension and Safety Study of Talazoparib

Open-Label Extension and Safety Study of Talazoparib. A Single-Arm, Open-Label, Multicenter, Extended Treatment, Safety Study in Patients Treated With Talazoparib.

Category & Conditions: Cancer
Medicine: TALZENNA™(TALAZOPARIB) CAPSULES
ClinicalTrials.gov Identifier (NCT): NCT02921919
Protocol ID: MDV3800-13 (C3441010)
    Share
PrintDownload
Open Plain Language Summary Result: Click here